Protalix BioTherapeutics Reports 2017 First Quarter Results and Provides Corporate Update
Go back to Protalix BioTherapeutics Reports 2017 First Quarter Results and Provides Corporate Update| PROTALIX BIOTHERAPEUTICS, INC. COMMON STOCK (NYSE: PLX) | Delayed: 2.69 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.69 | 52 Week High | $1.11 | |||
| Open | $2.69 | 52 Week Low | $0.41 | |||
| Day High | $2.69 | P/E | N/A | |||
| Day Low | $2.69 | EPS | $-0.29 | |||
| Volume | 1,010 | |||||
| PROTALIX BIOTHERAPEUTICS, INC. COMMON STOCK (NYSE: PLX) | Delayed: 2.69 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.69 | 52 Week High | $1.11 | |||
| Open | $2.69 | 52 Week Low | $0.41 | |||
| Day High | $2.69 | P/E | N/A | |||
| Day Low | $2.69 | EPS | $-0.29 | |||
| Volume | 1,010 | |||||
